Skip to content

Non-inflatable Supraglottic Airway (NI-SGA) vs. Face Mask (FM) as a Primary Interface Device for Neonatal Resuscitation

Non-inflatable Supraglottic Airway (NI-SGA) vs. Face Mask (FM) as a Primary Interface Device for Neonatal Resuscitation: A Pilot Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02629887
Enrollment
0
Registered
2015-12-14
Start date
2018-04-15
Completion date
2018-04-15
Last updated
2018-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Resuscitation

Keywords

supraglottic airway, neonatal resuscitation, ventilation, term infant

Brief summary

Prospective, randomized controlled trial to be performed at one center, of term and late preterm infants requiring resuscitation. Prenatal consent will be obtained. At randomization, babies will be resuscitated following Neonatal Resuscitation Program (NRP) guidelines and ventilated using the T-piece resuscitator with either a Face Mask (FM) or Non-inflating supraglottic airway. Video will be collected during resuscitation as well as written documentation. Primary outcome will be time to spontaneous breathing, length of resuscitation, and need for endotracheal intubation.

Detailed description

Mothers who are close to delivery of a term or near term infant with estimated fetal weight of 2500gms will be approached for consent to randomize their infant to resuscitation with mask or non-inflatable supraglottic airway (NISGA) if resuscitation is required. Study personnel in delivery will open sequential envelopes with randomized code to indicate which device is to be used if necessary. The resuscitator will be blinded until determination of need of respiratory support. At that time, the appropriate randomized device (face mask or NISGA) will be handed to the resuscitator for use along with T-Piece resuscitator. Video data capture will be used to record type, length and response to resuscitation. This information will be translated to a database prior to destruction of video.

Interventions

DEVICENon-inflatable supraglottic airway

at delivery if resuscitation is required infant randomized to NI-SGA or face mask as the interface for positive pressure ventilation.

DEVICEFace Mask

at delivery - standard airway management per Neonatal Resuscitation Program utilizing face mask.

DEVICET-Piece Resuscitator

T-Piece Resuscitator for providing postivie pressure ventilation via face mask or non-inflatable supraglottic airway

Sponsors

University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 30 Minutes
Healthy volunteers
No

Inclusion criteria

* Newborns \> or = 2000gms requiring positive pressure ventilation within the first 2 minutes of life

Exclusion criteria

* Newborns with expected fetal weight \<2000 grams * Known congenital malformations * Multiple gestation (twins and above) * History of meconium stained fluid

Design outcomes

Primary

MeasureTime frameDescription
Time to Spontaneous Breathing30 minutesRecord of time from beginning of resuscitation to time of spontaneous breathing
Duration of Positive Pressure Ventilation30 minutesTotal time of positive pressure ventilation required to adequate spontaneous breathing.
Need for subsequent endotracheal intubation30 minutesFailure of non-invasive resuscitative efforts by face mask or NI-SGA requiring intubation per NRP guideline.

Secondary

MeasureTime frameDescription
Use of oxygen30 minutesAmount and duration of oxygen use in resuscitation
Rate of complications associated with resuscitation30 minutesPresence of complications including bleeding, abdominal distension, laryngeal stridor
Time needed for NI-SGA placement1 minuteTime needed adequate placement of non-inflatable supraglottic airway
Maximum inspiratory pressure30 minutesRecord of highest peak inspiratory pressure used in resuscitation
Heart rate 2 minutes after initiation of resuscitation2 minutesHeart rate assessed at 2 minutes
Need for drugs in resuscitation30 minutesDrug administration as part of the standard neonatal resuscitation per NRP
Use of Chest Compressions30 minutesNeed for chest compressions as part of neonatal resuscitation per NRP guidelines

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026